Ibrutinib and venetoclax target distinct subpopulations of CLL cells: implication for residual disease eradication

Overview of attention for article published in Blood Cancer Journal, February 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 33,940 followers.

New article: Ibrutinib and venetoclax target distinct subpopulations of CLL cells: implication for residual disease eradication. https://t.co/Kyi7sdStxC #CLL #leusm #hematology

RT @smbenlazar: Ibrutinib and venetoclax target distinct subpopulations of CLL cells: implication for residual disease eradication https://…

Ibrutinib and venetoclax target distinct subpopulations of CLL cells: implication for residual disease eradication https://t.co/vshJNCjOi4

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.